Company profileListed on Iran Fara Bourse

Tehran Darou Pharmaceutical Company

Tehran Darou Pharmaceutical Company Public Joint Stock Company is a Tehran-based pharmaceutical manufacturer established in 1953 and listed on the Tehran Stock Exchange under the symbol دتهران (DTehran). It produces medicines and supplements in oral solid, liquid and topical forms for Iran’s domestic pharmacy, distributor and hospital channels, making it relevant to healthcare procurement and domestic drug-supply analysis.

ListingListed on Iran Fara Bourse
ExportLow
VerificationNeeds Update
ConfidenceMedium
Updated21/07/2026
OPERATING PROFILE

Operations & footprint

Products and services

Tehran Darou Pharmaceutical Company manufactures pharmaceutical products including gastrointestinal, nephrology, urology, antipyretic, supplement, oral solid, liquid, suspension, syrup, drop, ointment, capsule, and tablet forms. Its production supports domestic healthcare demand, pharmacy supply, medical distributors, hospital purchasing, and import-substitution pressure in common therapeutic categories.

Operations and assets

Tehran Darou manufactures pharmaceutical products in oral solid, liquid and topical dosage forms. Operations are conducted in line with Good Manufacturing Practices (GMP).

Geographic footprint

Tehran, Iran, with a domestic-market focus.

Investor Lens

Commercial and investment relevance

Tehran Darou is relevant for investors assessing Iran's domestic pharmaceutical manufacturing base, import substitution, drug-supply resilience, and the economics of smaller listed or semi-listed healthcare companies. It can support analysis of common medicine production, regulatory pricing, raw-material import dependence, distributor relationships, and working-capital pressure. Due diligence should verify current trading status, production continuity, licenses, product registrations, raw-material sourcing, receivables, shareholder structure, GMP compliance, and updated financial disclosures before any market or counterparty interpretation. The company is relevant to pharmaceutical distributors, healthcare buyers and suppliers seeking a domestic producer of common medicines and supplements across multiple dosage forms. Its product range supports local procurement and import-substitution demand.

DECISION RISKS

Constraints, risk & compliance

Key risks and constraints

The business is exposed to manufacturing and supply-chain requirements associated with maintaining GMP-compliant pharmaceutical production across its dosage-form portfolio.

LOCAL COMPANY ACCESS

Need more than a public profile?

Ask Hormuz to investigate, verify or act locally around Tehran Darou Pharmaceutical Company. Tell us exactly what you need.

Contact the companyVerify local presenceArrange a site visitRequest pricingCheck capacitySpeak with salesConfirm specific informationCover an exhibition
Open a Desk request No service is preselected.
Related context

Connected Intelligence

Relevant geography, industry, market and execution context for this profile.

Common questions

Frequently asked questions

Direct answers to the questions most likely to arise when reviewing this profile.

What does Tehran Darou Pharmaceutical Company produce?

Tehran Darou produces pharmaceuticals and supplements, including tablets, capsules, syrups, suspensions, drops and ointments. Its therapeutic coverage includes gastrointestinal, nephrology, urology and antipyretic products.

Is Tehran Darou Pharmaceutical Company listed?

Yes. Tehran Darou is a public joint stock company listed on the Tehran Stock Exchange under the symbol دتهران (DTehran).

Where is Tehran Darou based?

Tehran Darou is headquartered in Tehran, Tehran Province, Iran.